Presenter: Jennifer Allen, BFA, MS, LMFT, ATR-BC

INTERVIEW WITH JENNIFER ALLEN

THIS IS A ZOOM EVENT - Registration will close 48 hours before presentation.  Course meets the qualifications for 2 hours of continuing education credit for LMFTs, LCSWs, LPCCs and/or LEPs as required by the California Board of Behavioral Sciences.
Registrants must attend full 2 hours to receive 2 CEUs.

This is likely all new information and a new paradigm for most therapists as it is very new to the field all together and very few therapists have been trained for this; however, the implications for therapists in the next couple of years re: how clients will be treated and how that treatment impacts the way we orient to our work will impact many  therapists.

In this 2-hour course, we will cover a lot of new information about the two psychedelic drugs: MDMA and psilocybin that are currently being studied with promising success for PTSD and a myriad of other mental health issues respectively.  These two medicines are moving toward medical legalization rapidly. We will also touch on ketamine, which is already a legal prescription medication used for TRD.

We will look at the key ingredients to positive outcomes seen in the research to date: set, setting and integration and focus on ways  psychotherapy and integration are similar and different.          

Our country has a complicated history with psychedelics that cost us four decades of research and relief for so many who have suffered. With the tenacity of some passionate visionaries and researches—and a lot of private funding, there is a light at the end of the tunnel …and that is no hallucination!

Objectives:

1. Summarize the history of psychedelic use in mental health in the U.S.
2. Discuss results of at least 2 current psychedelic research studies.
3. Discuss implications for paradigm shift on how we treat mental health issues with psychedelics
4. Define FDA breakthrough status for a new drug
5. Discuss the importance of set, setting and integration in psychedelic assisted psychotherapy.

About the presenter:

Consciousness and creativity have been the ground to Jennifer Allen’s professional and personal endeavors. Using somatic art therapy, focusing, EMDR and Natural Processing in her clinical practice of over 20 years, she has specialized in trauma and grief of both young and old. In the past few years, she has shifted her focus to group and individual ketamine assisted psychotherapy and integration of non-ordinary states.

Jennifer has published Bone Knowing and Cinnamon Roll Sundays — an adult and a children’s book on anticipatory grief and created All SET thera-play games for kids and families. Jennifer’s art process and grief workshops have been offered at Esalen and other local venues.  More recently, she has provided Clinician’s Integration Retreats – offering experiential learning of non-ordinary state integration.

Just as Jennifer was initially thrilled to realize there was a field that combined psychology and creativity through Art Therapy, she now holds similar passion for the potential implications of the training she completed through California Institute of Integral Studies in Psychedelic Assisted Therapy and Research (2018) and the Ketamine Training Center (2109).  She has some exciting relevant news to share with us about the hope of this new/old cutting edge of mental health: psychedelics!

Inland Empire Chapter of CAMFT is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for IE-CAMFT. IE-CAMFT maintains responsibility for this program/course and its content. CEU  Provider # 62278

Event Policy Information